Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000319816 | SCV000335783 | likely benign | not specified | 2015-10-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000766772 | SCV000618158 | uncertain significance | not provided | 2024-10-19 | criteria provided, single submitter | clinical testing | Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000766772 | SCV001092545 | likely benign | not provided | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001142397 | SCV001302832 | uncertain significance | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Mayo Clinic Laboratories, |
RCV000766772 | SCV004224865 | uncertain significance | not provided | 2022-12-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004543028 | SCV004761698 | likely benign | MPV17-related disorder | 2022-04-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |